ZK1053.6

Caenorhabditis elegans

Predicted to enable monoatomic cation transmembrane transporter activity. Predicted to be involved in monoatomic cation transmembrane transport. Predicted to be located in plasma membrane.

ZK185.2

Caenorhabditis elegans

Predicted to enable monoatomic cation transmembrane transporter activity. Predicted to be involved in monoatomic cation transmembrane transport. Predicted to be located in plasma membrane. Is an ortholog of human SLC41A1 (solute carrier family 41 member 1) and SLC41A2 (solute carrier family 41 member 2).

K07H8.2

Caenorhabditis elegans

Predicted to enable monoatomic cation transmembrane transporter activity. Predicted to be involved in monoatomic cation transmembrane transport. Predicted to be located in plasma membrane. Is an ortholog of human SLC41A1 (solute carrier family 41 member 1) and SLC41A2 (solute carrier family 41 member 2).

ckb-2

Caenorhabditis elegans

Enables choline kinase activity. Involved in CDP-choline pathway and IRE1-mediated unfolded protein response. Predicted to be located in cytoplasm. Expressed in head and tail. Human ortholog(s) of this gene implicated in several diseases, including colon adenoma; megaconial type congenital muscular dystrophy; narcolepsy; and recurrent hypersomnia. Is an ortholog of human CHKA (choline kinase alpha) and CHKB (choline kinase beta).

cka-2

Caenorhabditis elegans

Enables choline kinase activity. Involved in CDP-choline pathway. Predicted to be located in cytoplasm. Human ortholog(s) of this gene implicated in several diseases, including colon adenoma; megaconial type congenital muscular dystrophy; narcolepsy; and recurrent hypersomnia. Is an ortholog of human CHKA (choline kinase alpha).

nipa-1

Caenorhabditis elegans

Predicted to enable magnesium ion transmembrane transporter activity. Involved in adult locomotory behavior. Located in neuronal cell body. Used to study hereditary spastic paraplegia. Human ortholog(s) of this gene implicated in autosomal recessive congenital ichthyosis 6 and hereditary spastic paraplegia 6. Is an ortholog of human NIPAL1 (NIPA like domain containing 1).

WBPaper00036123:Fluoranthene_regulated

t-test, p < 0.05. Genes that showed significant differential expressed between control and 1000 mg\/L Fluoranthene treatment.

WBPaper00064581:amygdalin_downregulated

DESeq2 Transcripts that showed significantly decreased expression in animals exposed to 2 mg per mL amygdalin for 48 hours.

WBPaper00036123:Atrazine_regulated

t-test, p < 0.05. Genes that showed significant differential expressed between control and 150 mg\/L Atrazine treatment.

WBPaper00036123:Cadmium_regulated

t-test, p < 0.05. Genes that showed significant differential expressed between control and 20 mg\/L Cadmium treatment.